Literature DB >> 15689446

Milroy disease and the VEGFR-3 mutation phenotype.

G Brice1, A H Child, A Evans, R Bell, S Mansour, K Burnand, M Sarfarazi, S Jeffery, P Mortimer.   

Abstract

Primary congenital lymphoedema (Milroy disease) is a rare autosomal dominant condition for which a major causative gene defect has recently been determined. Mutations in the vascular endothelial growth factor receptor 3 (VEGFR-3) gene have now been described in 13 families world-wide. This is a review of the condition based on the clinical findings in 71 subjects from 10 families. All 71 individuals have a mutation in VEGFR-3. Ninety per cent of the 71 individuals carrying a VEGFR-3 mutation showed signs of oedema, which was confined in all cases to the lower limbs. In all but two cases onset of swelling was from birth. Other symptoms and signs included cellulitis (20%), large calibre leg veins (23%), papillomatosis (10%), and upslanting toenails (10%). In males, hydrocoele was the next most common finding after oedema (37%). Thorough clinical examination of these patients indicates that there are few clinical signs in addition to lower limb oedema. Rigorous phenotyping of patients produces a high yield of VEGFR-3 mutations.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15689446      PMCID: PMC1735984          DOI: 10.1136/jmg.2004.024802

Source DB:  PubMed          Journal:  J Med Genet        ISSN: 0022-2593            Impact factor:   6.318


  18 in total

1.  Missense mutations interfere with VEGFR-3 signalling in primary lymphoedema.

Authors:  M J Karkkainen; R E Ferrell; E C Lawrence; M A Kimak; K L Levinson; M A McTigue; K Alitalo; D N Finegold
Journal:  Nat Genet       Date:  2000-06       Impact factor: 38.330

2.  Analysis of lymphoedema-distichiasis families for FOXC2 mutations reveals small insertions and deletions throughout the gene.

Authors:  R Bell; G Brice; A H Child; V A Murday; S Mansour; C J Sandy; J R Collin; A F Brady; D F Callen; K Burnand; P Mortimer; S Jeffery
Journal:  Hum Genet       Date:  2001-06       Impact factor: 4.132

3.  Mutations in FOXC2 (MFH-1), a forkhead family transcription factor, are responsible for the hereditary lymphedema-distichiasis syndrome.

Authors:  J Fang; S L Dagenais; R P Erickson; M F Arlt; M W Glynn; J L Gorski; L H Seaver; T W Glover
Journal:  Am J Hum Genet       Date:  2000-11-08       Impact factor: 11.025

4.  Segregation analyses and a genome-wide linkage search confirm genetic heterogeneity and suggest oligogenic inheritance in some Milroy congenital primary lymphedema families.

Authors:  C J Holberg; R P Erickson; M J Bernas; M H Witte; K E Fultz; M Andrade; C L Witte
Journal:  Am J Med Genet       Date:  2001-02-01

5.  Inhibition of lymphangiogenesis with resulting lymphedema in transgenic mice expressing soluble VEGF receptor-3.

Authors:  T Mäkinen; L Jussila; T Veikkola; T Karpanen; M I Kettunen; K J Pulkkanen; R Kauppinen; D G Jackson; H Kubo; S Nishikawa; S Ylä-Herttuala; K Alitalo
Journal:  Nat Med       Date:  2001-02       Impact factor: 53.440

6.  VEGF-C gene therapy augments postnatal lymphangiogenesis and ameliorates secondary lymphedema.

Authors:  Young-Sup Yoon; Toshinori Murayama; Edwin Gravereaux; Tengiz Tkebuchava; Marcy Silver; Cynthia Curry; Andrea Wecker; Rudolf Kirchmair; Chun Song Hu; Marianne Kearney; Alan Ashare; David G Jackson; Hajime Kubo; Jeffrey M Isner; Douglas W Losordo
Journal:  J Clin Invest       Date:  2003-03       Impact factor: 14.808

7.  Mapping of primary congenital lymphedema to the 5q35.3 region.

Authors:  A L Evans; G Brice; V Sotirova; P Mortimer; J Beninson; K Burnand; J Rosbotham; A Child; M Sarfarazi
Journal:  Am J Hum Genet       Date:  1999-02       Impact factor: 11.025

8.  Mutations in the transcription factor gene SOX18 underlie recessive and dominant forms of hypotrichosis-lymphedema-telangiectasia.

Authors:  Alexandre Irrthum; Koenraad Devriendt; David Chitayat; Gert Matthijs; Conrad Glade; Peter M Steijlen; Jean-Pierre Fryns; Maurice A M Van Steensel; Miikka Vikkula
Journal:  Am J Hum Genet       Date:  2003-05-08       Impact factor: 11.025

9.  Analysis of the phenotypic abnormalities in lymphoedema-distichiasis syndrome in 74 patients with FOXC2 mutations or linkage to 16q24.

Authors:  G Brice; S Mansour; R Bell; J R O Collin; A H Child; A F Brady; M Sarfarazi; K G Burnand; S Jeffery; P Mortimer; V A Murday
Journal:  J Med Genet       Date:  2002-07       Impact factor: 6.318

10.  Lymphangiogenic gene therapy with minimal blood vascular side effects.

Authors:  Anne Saaristo; Tanja Veikkola; Tuomas Tammela; Berndt Enholm; Marika J Karkkainen; Katri Pajusola; Hansruedi Bueler; Seppo Ylä-Herttuala; Kari Alitalo
Journal:  J Exp Med       Date:  2002-09-16       Impact factor: 14.307

View more
  33 in total

Review 1.  Pathogenesis of vascular anomalies.

Authors:  Laurence M Boon; Fanny Ballieux; Miikka Vikkula
Journal:  Clin Plast Surg       Date:  2011-01       Impact factor: 2.017

2.  Of mice and men; the translational physiology of a genetic form of lymphoedema.

Authors:  P S Mortimer; J R Levick
Journal:  J Physiol       Date:  2006-05-25       Impact factor: 5.182

3.  VEGF-C alters barrier function of cultured lymphatic endothelial cells through a VEGFR-3-dependent mechanism.

Authors:  Jerome W Breslin; Sarah Y Yuan; Mack H Wu
Journal:  Lymphat Res Biol       Date:  2007       Impact factor: 2.589

Review 4.  From germline towards somatic mutations in the pathophysiology of vascular anomalies.

Authors:  Nisha Limaye; Laurence M Boon; Miikka Vikkula
Journal:  Hum Mol Genet       Date:  2009-04-15       Impact factor: 6.150

Review 5.  Developmental and pathological lymphangiogenesis: from models to human disease.

Authors:  Hélène Maby-El Hajjami; Tatiana V Petrova
Journal:  Histochem Cell Biol       Date:  2008-10-23       Impact factor: 4.304

Review 6.  New developments in clinical aspects of lymphatic disease.

Authors:  Peter S Mortimer; Stanley G Rockson
Journal:  J Clin Invest       Date:  2014-03-03       Impact factor: 14.808

7.  Puffy feet in a female neonate.

Authors:  Rita Espírito Santo; Oana Moldovan; Paula Costa; André Graça; Margarida Abrantes
Journal:  BMJ Case Rep       Date:  2016-08-10

Review 8.  Lymphatic pumping: mechanics, mechanisms and malfunction.

Authors:  Joshua P Scallan; Scott D Zawieja; Jorge A Castorena-Gonzalez; Michael J Davis
Journal:  J Physiol       Date:  2016-08-02       Impact factor: 5.182

9.  The secreted lymphangiogenic factor CCBE1 is essential for fetal liver erythropoiesis.

Authors:  Zhiying Zou; David R Enis; Hung Bui; Eugene Khandros; Vinayak Kumar; Zoltan Jakus; Christopher Thom; Yiqing Yang; Veerpal Dhillon; Mei Chen; Minmin Lu; Mitchell J Weiss; Mark L Kahn
Journal:  Blood       Date:  2013-02-20       Impact factor: 22.113

10.  Normal dendritic cell mobilization to lymph nodes under conditions of severe lymphatic hypoplasia.

Authors:  Andrew M Platt; Joseph M Rutkowski; Catherine Martel; Emma L Kuan; Stoyan Ivanov; Melody A Swartz; Gwendalyn J Randolph
Journal:  J Immunol       Date:  2013-03-25       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.